Independent real-world application of a clinical-grade automated prostate cancer detection system.
Independent real-world application of a clinical-grade automated prostate cancer detection system.
复制标题
临床级自动前列腺癌检测系统的独立现实应用。
DOI:
10.1002/path.5662
复制
发表时间:
2021-06
期刊:
影响因子:
--
通讯作者:
Reis-Filho JS
中科院分区:
文献类型:
--
作者:
da Silva LM;Pereira EM;Salles PG;Godrich R;Ceballos R;Kunz JD;Casson A;Viret J;Chandarlapaty S;Ferreira CG;Ferrari B;Rothrock B;Raciti P;Reuter V;Dogdas B;DeMuth G;Sue J;Kanan C;Grady L;Fuchs TJ;Reis-Filho JS
Artificial intelligence (AI)‐based systems applied to histopathology whole‐slide images have the potential to improve patient care through mitigation of challenges posed by diagnostic variability, histopathology caseload, and shortage of pathologists. We sought to define the performance of an AI‐based automated prostate cancer detection system, Paige Prostate, when applied to independent real‐world data. The algorithm was employed to classify slides into two categories: benign (no further review needed) or suspicious (additional histologic and/or immunohistochemical analysis required). We assessed the sensitivity, specificity, positive predictive values (PPVs), and negative predictive values (NPVs) of a local pathologist, two central pathologists, and Paige Prostate in the diagnosis of 600 transrectal ultrasound‐guided prostate needle core biopsy regions (‘part‐specimens’) from 100 consecutive patients, and to ascertain the impact of Paige Prostate on diagnostic accuracy and efficiency. Paige Prostate displayed high sensitivity (0.99; CI 0.96–1.0), NPV (1.0; CI 0.98–1.0), and specificity (0.93; CI 0.90–0.96) at the part‐specimen level. At the patient level, Paige Prostate displayed optimal sensitivity (1.0; CI 0.93–1.0) and NPV (1.0; CI 0.91–1.0) at a specificity of 0.78 (CI 0.64–0.89). The 27 part‐specimens considered by Paige Prostate as suspicious, whose final diagnosis was benign, were found to comprise atrophy (n = 14), atrophy and apical prostate tissue (n = 1), apical/benign prostate tissue (n = 9), adenosis (n = 2), and post‐atrophic hyperplasia (n = 1). Paige Prostate resulted in the identification of four additional patients whose diagnoses were upgraded from benign/suspicious to malignant. Additionally, this AI‐based test provided an estimated 65.5% reduction of the diagnostic time for the material analyzed. Given its optimal sensitivity and NPV, Paige Prostate has the potential to be employed for the automated identification of patients whose histologic slides could forgo full histopathologic review. In addition to providing incremental improvements in diagnostic accuracy and efficiency, this AI‐based system identified patients whose prostate cancers were not initially diagnosed by three experienced histopathologists. © 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.
登录
查看更多内容
影响因子:
3.4
作者:
Cree IA;Deans Z;Ligtenberg MJ;Normanno N;Edsjö A;Rouleau E;Solé F;Thunnissen E;Timens W;Schuuring E;Dequeker E;Murray S;Dietel M;Groenen P;Van Krieken JH;European Society of Pathology Task Force on Quality Assurance in Molecular Pathology;Royal College of Pathologists
通讯作者:
Royal College of Pathologists
影响因子:
4.6
作者:
Yang, Chen;Humphrey, Peter A.
通讯作者:
Humphrey, Peter A.
影响因子:
7.5
作者:
Raciti, Patricia;Sue, Jillian;Ceballos, Rodrigo;Godrich, Ran;Kunz, Jeremy D.;Kapur, Supriya;Reuter, Victor;Grady, Leo;Kanan, Christopher;Klimstra, David S.;Fuchs, Thomas J.
通讯作者:
Fuchs, Thomas J.
影响因子:
3.8
作者:
Howlader, Nupur Rani;Rahman, Md. Mostafizur;Rahman, Md. Mustafizur
通讯作者:
Rahman, Md. Mustafizur
影响因子:
4.6
作者:
Hitchcock, Charles L.
通讯作者:
Hitchcock, Charles L.